Raymond James Financial
RGEN icon

Raymond James Financial’s Repligen RGEN Stock Holding History

Raymond James Financial’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.6M Buy
172,826
+3,964
+2% +$487K 0.01% 1438
2026
Q1 		$19.4M Sell
168,862
-12
-0% -$1.68K 0.01% 1494
2025
Q4 		$27.9M Buy
168,874
+18,732
+12% +$2.93M 0.01% 1214
2025
Q3 		$20.1M Sell
150,142
-205,902
-58% -$25M 0.01% 1410
2025
Q2 		$44.3M Sell
356,044
-4,716
-1% -$600K 0.02% 831
2025
Q1 		$45.9M Sell
360,760
-3,921
-1% -$604K 0.02% 764
2024
Q4 		$52.5M Buy
+364,681
New +$52.3M 0.02% 699

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Raymond James Financial's RGEN Position: Q2 2026 in Review

Raymond James Financial increased its Repligen (RGEN) stake by 2.3% in Q2 2026, buying an estimated $487K and bringing the position to 172,826 shares worth $23.6M. The position accounts for 0.01% of the portfolio, ranked #1438.

Raymond James Financial first reported a position in RGEN in Q4 2024 and has held it in 7 quarters since. The position peaked at $52.5M in Q4 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Raymond James Financial held 172,826 shares of Repligen worth $23.6M as of Q2 2026.
  • Raymond James Financial bought 3,964 Repligen shares in Q2 2026, an estimated $487K.
  • Repligen made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1438 holding.
  • Raymond James Financial first reported a position in Repligen in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Repligen position peaked at $52.5M in Q4 2024.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.